Firtecan pegol Terminated Phase 2 Trials for Metastatic Breast Cancer Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Terminated | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01036113 | A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer |